Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022

In Los Angeles, California, USA, persistent, refractory shigellosis was diagnosed in an immunocompetent man who has sex with men. Whole-genome sequencing augmented phenotypic antimicrobial susceptibility testing to comprehensively profile bacterial drug resistance and appropriately guide therapy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldera, J.R., Yang, Shangxin, Uslan, Daniel Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310382/
https://www.ncbi.nlm.nih.gov/pubmed/37204919
http://dx.doi.org/10.3201/eid2907.230465
_version_ 1785066527582584832
author Caldera, J.R.
Yang, Shangxin
Uslan, Daniel Z.
author_facet Caldera, J.R.
Yang, Shangxin
Uslan, Daniel Z.
author_sort Caldera, J.R.
collection PubMed
description In Los Angeles, California, USA, persistent, refractory shigellosis was diagnosed in an immunocompetent man who has sex with men. Whole-genome sequencing augmented phenotypic antimicrobial susceptibility testing to comprehensively profile bacterial drug resistance and appropriately guide therapy and clear the infection.
format Online
Article
Text
id pubmed-10310382
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-103103822023-07-01 Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022 Caldera, J.R. Yang, Shangxin Uslan, Daniel Z. Emerg Infect Dis Research Letter In Los Angeles, California, USA, persistent, refractory shigellosis was diagnosed in an immunocompetent man who has sex with men. Whole-genome sequencing augmented phenotypic antimicrobial susceptibility testing to comprehensively profile bacterial drug resistance and appropriately guide therapy and clear the infection. Centers for Disease Control and Prevention 2023-07 /pmc/articles/PMC10310382/ /pubmed/37204919 http://dx.doi.org/10.3201/eid2907.230465 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Caldera, J.R.
Yang, Shangxin
Uslan, Daniel Z.
Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022
title Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022
title_full Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022
title_fullStr Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022
title_full_unstemmed Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022
title_short Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022
title_sort extensively drug-resistant shigella flexneri 2a, california, usa, 2022
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310382/
https://www.ncbi.nlm.nih.gov/pubmed/37204919
http://dx.doi.org/10.3201/eid2907.230465
work_keys_str_mv AT calderajr extensivelydrugresistantshigellaflexneri2acaliforniausa2022
AT yangshangxin extensivelydrugresistantshigellaflexneri2acaliforniausa2022
AT uslandanielz extensivelydrugresistantshigellaflexneri2acaliforniausa2022

Ejemplares similares